The global glucose tolerance test market is slated to grow enormously on the basis of a notable increase in diabetic population worldwide. Timely execution of glucose tolerance test helps in resorting to preventive/curative measures with immediate effect.
Various government and non-government agencies are making efforts to fund research regarding diabetes diagnostics and therapeutics.
The companies operating in the glucose tolerance test market are exploring the incorporation of a 1-hour glucose test for diagnosing risk of diabetes. This would help in speeding up the detection of gestational diabetes as women would feel relaxed on the early outcomes of glucose tolerance tests.
The glucose tolerance test’s functionality includes measuring the response of the body to sugar. It can be performed regarding type 2 diabetes/prediabetes.
It may also help in finding out if diabetes is the cause of any symptoms that exist. One of the versions of this test is used for checking for diabetes that occurs during pregnancy. This condition is termed as ‘gestational diabetes’.
The glucose tolerance test locates problems with the way in which body handles sugar post-meals. The body breaks down food into sugar as one eats. This sugar enters the blood, and body makes use of this sugar for energy. However, with diabetes and prediabetes, this level of sugar is pretty high.
As per the IDF, 10% of the global population is diabetic and the percentage is likely to increase substantially during the forecast period. This factor is expected to contribute toward an exponential growth of glucose tolerance test market going forward, as timely diagnosis will help in combating the ailment.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
The glucose tolerance test is referred to as a lab test that checks the way body moves sugar from blood into the tissues such as fat and muscles. It is generally used for diagnosing diabetes.
One of the common glucose tolerance tests is oral glucose tolerance test (OGTT). Before starting of the test, he/she should be empty stomach for atleast 8 hours.
After the blood sample is taken, he/she would be asked to consume a liquid that would contain a certain quantity of glucose (75 grams). The blood sample is then taken again every 30-60 minutes after drinking the solution.
Intravenous (IV) glucose tolerance test (IGTT) is rarely used for detecting diabetes.
The basic purpose behind performing glucose tolerance test is to check the utilization of sugar by the body. Individuals living with untreated diabetes tend to have higher blood glucose levels.
As per the International Diabetes federation (IDF) Diabetes Atlas, diabetes had affected 537 million adults in 2021. This number is expected to increase to 643 million by the year 2030 and 783 million by the year 2045.
Need to detect diabetes on a timely basis to avoid further onslaught is thus catalyzing the glucose tolerance test market opportunities.
The American Diabetes Association makes provisions for critical funding for research pertaining to diabetes. The goal is that of ascertaining appropriate monetary resources to extend support to innovative scientific discovery translating into life-altering treatments.
As per the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), 38.4 million individuals suffer from diabetes in the U.S. alone. NIDDK provides financial support to clinical, basic, and translational research in order to combat diabetes and the complications associated with it.
For instance, researchers funded by NIDDK are conducting research on environmental and genetic factors contributing to progression of diabetes, identifying ways of improving diabetes health quality and reducing diabetes health disparities, examining behavioral approaches to avert type 2 diabetes and improve diabetes self-management, and likewise.
Continual funding for research regarding the causes and treatment for diabetes is thus expanding the glucose tolerance test industry size.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest glucose tolerance test market analysis, North America dominated the blood sugar tolerance test in 2023 and the status quo is expected to remain unchanged during the forecast period.
This is attributed to increase in healthcare expenditure, rising cases of diabetes, and technological advancements. The U.S. is also home to a large number of individuals suffering from diabetes.
Asia Pacific’s sizable glucose tolerance test market growth is due to the presence of densely populated countries in the region. The other factor is improvement in healthcare infrastructure.
The key players in glucose tolerance test market are deploying various strategies such as new product launch, updating the existing product, banking on the successful products, and inorganic modes of expansion in order to sustain themselves.
For instance, Salimetrics has been successfully running its testing protocols in order to study adult and childhood obesity such as heart disease, metabolic syndrome, and type II diabetes.
LifeScan IP Holdings, Bayer AG, DexCom, Inc., Abbott Laboratories, E-ZLab, Cenogenics Corporation, Quest Diagnostics Incorporated, Merck KGaA, F. Hoffmann-La Roche Ltd, Johnson & Johnson Inc., Ascensia Diabetes Care Holdings AG, and Trividia Health Inc. are some of the key players covered in the glucose tolerance test market report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 61.4 Bn |
| Market Forecast (Value) in 2034 | US$ 183.2 Bn |
| Growth Rate (CAGR) | 10.5% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 61.4 Bn in 2023
It is projected to grow at a CAGR of 10.5% from 2024 to 2034
Rise in the number of diabetic patients and increase in investment in research funding for diagnosis and treatment of diabetes
Diagnostic centers segment accounted for the largest share in 2023
North America was the dominant region in 2023
LifeScan IP Holdings, Bayer AG, DexCom, Inc., Abbott Laboratories, E-ZLab, Cenogenics Corporation, Quest Diagnostics Incorporated, Merck KGaA, F. Hoffmann-La Roche Ltd, Johnson & Johnson Inc., Ascensia Diabetes Care Holdings AG, and Trividia Health Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Glucose Tolerance Test Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Glucose Tolerance Test Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Glucose Tolerance Test Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2020-2034
6.3.1. Smart Sensors
6.3.2. Blood Glucose Testing Kit
6.3.3. Meters
6.3.4. Others (Test Slips, etc.)
6.4. Market Attractiveness Analysis, by Product Type
7. Global Glucose Tolerance Test Market Analysis and Forecast, by Disease Indication
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Disease Indication, 2020-2034
7.3.1. Reactive Hypoglycemia
7.3.2. Diabetes Hypoglycemia
7.3.3. Gestational Diabetes
7.3.4. Others (Insulin Resistance, etc.)
7.4. Market Attractiveness Analysis, by Disease Indication
8. Global Glucose Tolerance Test Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals & Clinics
8.3.2. Homecare Settings
8.3.3. Diagnostic Centers
8.3.4. Others (Research Institutes, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global Glucose Tolerance Test Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Glucose Tolerance Test Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2020-2034
10.3.1. Smart Sensors
10.3.2. Blood Glucose Testing Kit
10.3.3. Meters
10.3.4. Others (Test Slips, etc.)
10.4. Market Value Forecast, by Disease Indication, 2020-2034
10.4.1. Reactive Hypoglycemia
10.4.2. Diabetes Hypoglycemia
10.4.3. Gestational Diabetes
10.4.4. Others (Insulin Resistance, etc.)
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals & Clinics
10.5.2. Homecare Settings
10.5.3. Diagnostic Centers
10.5.4. Others (Research Institutes, etc.)
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product Type
10.7.2. By Disease Indication
10.7.3. By End-user
10.7.4. By Country
11. Europe Glucose Tolerance Test Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2020-2034
11.3.1. Smart Sensors
11.3.2. Blood Glucose Testing Kit
11.3.3. Meters
11.3.4. Others (Test Slips, etc.)
11.4. Market Value Forecast, by Disease Indication, 2020-2034
11.4.1. Reactive Hypoglycemia
11.4.2. Diabetes Hypoglycemia
11.4.3. Gestational Diabetes
11.4.4. Others (Insulin Resistance, etc.)
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals & Clinics
11.5.2. Homecare Settings
11.5.3. Diagnostic Centers
11.5.4. Others (Research Institutes, etc.)
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Disease Indication
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Glucose Tolerance Test Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2020-2034
12.3.1. Smart Sensors
12.3.2. Blood Glucose Testing Kit
12.3.3. Meters
12.3.4. Others (Test Slips, etc.)
12.4. Market Value Forecast, by Disease Indication, 2020-2034
12.4.1. Reactive Hypoglycemia
12.4.2. Diabetes Hypoglycemia
12.4.3. Gestational Diabetes
12.4.4. Others (Insulin Resistance, etc.)
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals & Clinics
12.5.2. Homecare Settings
12.5.3. Diagnostic Centers
12.5.4. Others (Research Institutes, etc.)
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Disease Indication
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Glucose Tolerance Test Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product Type, 2020-2034
13.3.1. Smart Sensors
13.3.2. Blood Glucose Testing Kit
13.3.3. Meters
13.3.4. Others (Test Slips, etc.)
13.4. Market Value Forecast, by Disease Indication, 2020-2034
13.4.1. Reactive Hypoglycemia
13.4.2. Diabetes Hypoglycemia
13.4.3. Gestational Diabetes
13.4.4. Others (Insulin Resistance, etc.)
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals & Clinics
13.5.2. Homecare Settings
13.5.3. Diagnostic Centers
13.5.4. Others (Research Institutes, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Disease Indication
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Glucose Tolerance Test Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product Type, 2020-2034
14.3.1. Smart Sensors
14.3.2. Blood Glucose Testing Kit
14.3.3. Meters
14.3.4. Others (Test Slips, etc.)
14.4. Market Value Forecast, by Disease Indication, 2020-2034
14.4.1. Reactive Hypoglycemia
14.4.2. Diabetes Hypoglycemia
14.4.3. Gestational Diabetes
14.4.4. Others (Insulin Resistance, etc.)
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals & Clinics
14.5.2. Homecare Settings
14.5.3. Diagnostic Centers
14.5.4. Others (Research Institutes, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Disease Indication
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. LifeScan IP Holdings
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Bayer AG
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. DexCom, Inc.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Abbott Laboratories
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. E-ZLab
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Cenogenics Corporation
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Quest Diagnostics Incorporated
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Merck KGaA
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. F. Hoffmann-La Roche Ltd
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Johnson & Johnson Inc.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Ascensia Diabetes Care Holdings AG
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. Trividia Health Inc.
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
List of Tables
Table 01: Global Glucose Tolerance Test Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 02: Global Glucose Tolerance Test Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 03: Global Glucose Tolerance Test Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 04: Global Glucose Tolerance Test Market Size (US$ Bn) Forecast, by Region, 2020-2034
Table 05: North America Glucose Tolerance Test Market Size (US$ Bn) Forecast, by Country, 2020-2034
Table 06: North America Glucose Tolerance Test Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 07: North America Glucose Tolerance Test Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 08: North America Glucose Tolerance Test Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 09: Europe Glucose Tolerance Test Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Glucose Tolerance Test Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 11: Europe Glucose Tolerance Test Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 12: Europe Glucose Tolerance Test Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific Glucose Tolerance Test Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Glucose Tolerance Test Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 15: Asia Pacific Glucose Tolerance Test Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 16: Asia Pacific Glucose Tolerance Test Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 17: Latin America Glucose Tolerance Test Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Glucose Tolerance Test Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 19: Latin America Glucose Tolerance Test Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 20: Latin America Glucose Tolerance Test Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa Glucose Tolerance Test Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Glucose Tolerance Test Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 23: Middle East & Africa Glucose Tolerance Test Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 24: Middle East & Africa Glucose Tolerance Test Market Size (US$ Bn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Glucose Tolerance Test Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Glucose Tolerance Test Market Revenue (US$ Bn), by Product Type, 2023
Figure 03: Global Glucose Tolerance Test Market Value Share, by Product Type, 2023
Figure 04: Global Glucose Tolerance Test Market Revenue (US$ Bn), by Disease Indication, 2023
Figure 05: Global Glucose Tolerance Test Market Value Share, by Disease Indication, 2023
Figure 06: Global Glucose Tolerance Test Market Revenue (US$ Bn), by End-user, 2023
Figure 07: Global Glucose Tolerance Test Market Value Share, by End-user, 2023
Figure 08: Global Glucose Tolerance Test Market Value Share, by Region, 2023
Figure 09: Global Glucose Tolerance Test Market Value (US$ Bn) Forecast, 2020-2034
Figure 10: Global Glucose Tolerance Test Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 11: Global Glucose Tolerance Test Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Glucose Tolerance Test Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 13: Global Glucose Tolerance Test Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 14: Global Glucose Tolerance Test Market Value Share Analysis, by End-user, 2023 and 2034
Figure 15: Global Glucose Tolerance Test Market Attractiveness Analysis, by End-user, 2024-2034
Figure 16: Global Glucose Tolerance Test Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Glucose Tolerance Test Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Glucose Tolerance Test Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Glucose Tolerance Test Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Glucose Tolerance Test Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Glucose Tolerance Test Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 22: North America Glucose Tolerance Test Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 23: North America Glucose Tolerance Test Market Value Share Analysis, by End-user, 2023 and 2034
Figure 24: North America Glucose Tolerance Test Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Glucose Tolerance Test Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 26: North America Glucose Tolerance Test Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Europe Glucose Tolerance Test Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Glucose Tolerance Test Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Glucose Tolerance Test Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Glucose Tolerance Test Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 31: Europe Glucose Tolerance Test Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 32: Europe Glucose Tolerance Test Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Europe Glucose Tolerance Test Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Glucose Tolerance Test Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 35: Europe Glucose Tolerance Test Market Attractiveness Analysis, by End-user, 2024-2034
Figure 36: Asia Pacific Glucose Tolerance Test Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Glucose Tolerance Test Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Glucose Tolerance Test Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Glucose Tolerance Test Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 40: Asia Pacific Glucose Tolerance Test Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 41: Asia Pacific Glucose Tolerance Test Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Asia Pacific Glucose Tolerance Test Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Glucose Tolerance Test Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 44: Asia Pacific Glucose Tolerance Test Market Attractiveness Analysis, by End-user, 2024-2034
Figure 45: Latin America Glucose Tolerance Test Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Glucose Tolerance Test Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Glucose Tolerance Test Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Glucose Tolerance Test Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 49: Latin America Glucose Tolerance Test Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 50: Latin America Glucose Tolerance Test Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Latin America Glucose Tolerance Test Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Glucose Tolerance Test Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 53: Latin America Glucose Tolerance Test Market Attractiveness Analysis, by End-user, 2024-2034
Figure 54: Middle East & Africa Glucose Tolerance Test Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Glucose Tolerance Test Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Glucose Tolerance Test Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Glucose Tolerance Test Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 58: Middle East & Africa Glucose Tolerance Test Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 59: Middle East & Africa Glucose Tolerance Test Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Middle East & Africa Glucose Tolerance Test Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Glucose Tolerance Test Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 62: Middle East & Africa Glucose Tolerance Test Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Glucose Tolerance Test Market
